Levetiracetam Neuraxpharm (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates the release of neurotransmitters. This action stabilises neuronal firing and reduces the hyper‑excitability that leads to seizure activity.

The dosage of levetiracetam is individualized by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Only a qualified healthcare professional should determine the appropriate regimen.

Safety data are limited. Levetiracetam should only be used during pregnancy or lactation if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Consultation with a specialist is recommended.

Enquiries are submitted via the product page at gnhindia.com, where you specify the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers or GABA‑enhancers. It generally has fewer drug‑enzyme interactions, a favorable pharmacokinetic profile, and is often chosen when patients experience side effects with other agents.

Levetiracetam Neuraxpharm tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children.

The medication is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with water and not crushed or chewed unless specifically advised.

Serious risks include severe allergic reactions such as anaphylaxis, life‑threatening skin conditions like Stevens‑Johnson syndrome, and significant mood alterations including depression or suicidal thoughts. Immediate medical attention is required if any of these occur.

Patients with known hypersensitivity to levetiracetam or any of its excipients should avoid the drug. Caution is also advised for individuals with severe renal impairment, uncontrolled psychiatric disorders, or those who are pregnant without a clear therapeutic justification.